193 related articles for article (PubMed ID: 23847209)
1. Pseudophosphatase STYX modulates cell-fate decisions and cell migration by spatiotemporal regulation of ERK1/2.
Reiterer V; Fey D; Kolch W; Kholodenko BN; Farhan H
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):E2934-43. PubMed ID: 23847209
[TBL] [Abstract][Full Text] [Related]
2. STYX: a versatile pseudophosphatase.
Reiterer V; Pawłowski K; Farhan H
Biochem Soc Trans; 2017 Apr; 45(2):449-456. PubMed ID: 28408485
[TBL] [Abstract][Full Text] [Related]
3. The pseudophosphatase MK-STYX induces neurite-like outgrowths in PC12 cells.
Flowers BM; Rusnak LE; Wong KE; Banks DA; Munyikwa MR; McFarland AG; Hinton SD
PLoS One; 2014; 9(12):e114535. PubMed ID: 25479605
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone and protein kinase C signaling to ERK: spatiotemporal regulation of ERK by docking domains and dual-specificity phosphatases.
Armstrong SP; Caunt CJ; McArdle CA
Mol Endocrinol; 2009 Apr; 23(4):510-9. PubMed ID: 19179479
[TBL] [Abstract][Full Text] [Related]
5. Dual specificity phosphatases 10 and 16 are positive regulators of EGF-stimulated ERK activity: indirect regulation of ERK signals by JNK/p38 selective MAPK phosphatases.
Finch AR; Caunt CJ; Perrett RM; Tsaneva-Atanasova K; McArdle CA
Cell Signal; 2012 May; 24(5):1002-11. PubMed ID: 22245064
[TBL] [Abstract][Full Text] [Related]
6. The pseudophosphatase MK-STYX interacts with G3BP and decreases stress granule formation.
Hinton SD; Myers MP; Roggero VR; Allison LA; Tonks NK
Biochem J; 2010 Apr; 427(3):349-57. PubMed ID: 20180778
[TBL] [Abstract][Full Text] [Related]
7. Pseudophosphatases as Regulators of MAPK Signaling.
Hepworth EMW; Hinton SD
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830476
[TBL] [Abstract][Full Text] [Related]
8. Spatiotemporal regulation of ERK2 by dual specificity phosphatases.
Caunt CJ; Armstrong SP; Rivers CA; Norman MR; McArdle CA
J Biol Chem; 2008 Sep; 283(39):26612-23. PubMed ID: 18650424
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic roles for STYX pseudophosphatases in neurite outgrowth.
Dahal A; Hinton SD
Biochem Soc Trans; 2017 Apr; 45(2):381-387. PubMed ID: 28408478
[TBL] [Abstract][Full Text] [Related]
10. Regulation of angiopoietin-1/Tie-2 receptor signaling in endothelial cells by dual-specificity phosphatases 1, 4, and 5.
Echavarria R; Hussain SN
J Am Heart Assoc; 2013 Dec; 2(6):e000571. PubMed ID: 24308939
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor and protein kinase C signaling to ERK2: spatiotemporal regulation of ERK2 by dual specificity phosphatases.
Caunt CJ; Rivers CA; Conway-Campbell BL; Norman MR; McArdle CA
J Biol Chem; 2008 Mar; 283(10):6241-52. PubMed ID: 18178562
[TBL] [Abstract][Full Text] [Related]
12. Pseudophosphatase MK-STYX: the atypical member of the MAP kinase phosphatases.
Hinton SD
FEBS J; 2020 Oct; 287(19):4221-4231. PubMed ID: 32472731
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition.
Cagnol S; Rivard N
Oncogene; 2013 Jan; 32(5):564-76. PubMed ID: 22430215
[TBL] [Abstract][Full Text] [Related]
14. Dual specificity phosphatase (DUSP)-4 is induced by platelet-derived growth factor -BB in an Erk1/2-, STAT3- and p53-dependent manner.
Yin R; Eger G; Sarri N; Rorsman C; Heldin CH; Lennartsson J
Biochem Biophys Res Commun; 2019 Nov; 519(3):469-474. PubMed ID: 31526568
[TBL] [Abstract][Full Text] [Related]
15. VEGF autoregulates its proliferative and migratory ERK1/2 and p38 cascades by enhancing the expression of DUSP1 and DUSP5 phosphatases in endothelial cells.
Bellou S; Hink MA; Bagli E; Panopoulou E; Bastiaens PI; Murphy C; Fotsis T
Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1477-89. PubMed ID: 19741200
[TBL] [Abstract][Full Text] [Related]
16. E1a gene expression blocks the ERK1/2 signaling pathway by promoting nuclear localization and MKP up-regulation: implication in v-H-Ras-induced senescence.
Callejas-Valera JL; Guinea-Viniegra J; Ramírez-Castillejo C; Recio JA; Galan-Moya E; Martinez N; Rojas JM; Ramón y Cajal S; Sánchez-Prieto R
J Biol Chem; 2008 May; 283(19):13450-8. PubMed ID: 18316372
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of DUSP activity in EGFR-mutant lung cancer cell lines contributes to sustained ERK1/2 signaling.
Britson JS; Barton F; Balko JM; Black EP
Biochem Biophys Res Commun; 2009 Dec; 390(3):849-54. PubMed ID: 19836351
[TBL] [Abstract][Full Text] [Related]
18. Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF.
Andreu-Pérez P; Esteve-Puig R; de Torre-Minguela C; López-Fauqued M; Bech-Serra JJ; Tenbaum S; García-Trevijano ER; Canals F; Merlino G; Avila MA; Recio JA
Sci Signal; 2011 Sep; 4(190):ra58. PubMed ID: 21917714
[TBL] [Abstract][Full Text] [Related]
19. Evolutionary genomic relationships and coupling in MK-STYX and STYX pseudophosphatases.
Qi Y; Kuang D; Kelley K; Buchser WJ; Hinton SD
Sci Rep; 2022 Mar; 12(1):4139. PubMed ID: 35264672
[TBL] [Abstract][Full Text] [Related]
20. TP53INP1 Downregulation Activates a p73-Dependent DUSP10/ERK Signaling Pathway to Promote Metastasis of Hepatocellular Carcinoma.
Ng KY; Chan LH; Chai S; Tong M; Guan XY; Lee NP; Yuan Y; Xie D; Lee TK; Dusetti NJ; Carrier A; Ma S
Cancer Res; 2017 Sep; 77(17):4602-4612. PubMed ID: 28674078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
